Clinical Trial Update: Open Label Pilot Study of Apremilast in Treatment of Rosacea [Phase 2]

View source ↗

Summary

Open-label Phase 2 pilot study of apremilast for rosacea has completed and posted results. The trial included erythematotelangiectatic and papulopustular rosace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• OTEZLA (apremilast)

Snippet

Sponsor: Julian M. Mackay-Wiggan | Conditions: Erythematotelangiectatic Rosacea, Papulopustular Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2016-10-04